Status:
UNKNOWN
Oral Postbiotics in Patients With Macular Atrophy
Lead Sponsor:
Institut de la Macula y la Retina
Collaborating Sponsors:
Igen BioLab SLU
Conditions:
Geographic Atrophy
Age-Related Macular Degeneration
Eligibility:
All Genders
55-100 years
Phase:
NA
Brief Summary
A pilot study to evaluate the safety and efficacy of oral therapy with Postbiotics in patients with geographic atrophy secondary to age-related macular degeneration, myopia, or angioid streaks.
Detailed Description
A pilot study to evaluate the safety and efficacy of oral therapy with Postbiotics in patients with geographic atrophy (GA) secondary to age-related macular degeneration, myopia or angioid streaks. T...
Eligibility Criteria
Inclusion
- patients with GA secondary to AMD, myopia or angioid streaks
- with 12 months of previous follow-up,
- and a known progression of \>0,20mm/year as per SQRT
Exclusion
- \- history of choroidal neovascularization in the study eye
Key Trial Info
Start Date :
December 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2024
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT05391074
Start Date
December 1 2020
End Date
June 1 2024
Last Update
June 24 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut de la Màcula
Barcelona, Spain, 08022